Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1608704

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1608704

Cell-free Protein Expression Market, By Product Type, By Application, By End User, By Geography

PUBLISHED:
PAGES: 182 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The cell-free protein expression market is estimated to be valued at USD 318.1 Mn in 2024 and is expected to reach USD 512.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 318.1 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 7.10% 2031 Value Projection: 512.7 Mn
Figure. Cell-free Protein Expression Market Share (%), By Region, 2024
Cell-free Protein Expression Market - IMG1

Cell-free protein expression, also known as in vitro protein synthesis, is a biotechnological process that utilizes cellular components like ribosomes, amino acids, DNA/mRNA, and other factors from bacteria, yeast, or other cells to produce active proteins outside living cells in a test tube. Rather than using live organisms like bacteria or yeast to produce proteins, cell-free systems provide a flexible toolkit to program expression through mechanisms like transcription and translation outside living cells in an easily controlled environment. This allows proteins which are toxic to the host cell or difficult to express intracellularly to be produced using cell-free methods. The cell-free protein expression market is growing due to the increasing demand for rapid, scalable, and cost-effective techniques for protein production across industries like biopharmaceuticals, synthetic biology, and basic biological research.

Market Dynamics:

The major drivers fueling growth in the cell-free protein expression market include rising demand for functional and native human proteins in biomedical research and therapeutics development. Cell-free systems allow rapid, scalable, and economical evaluation of multiple protein variants without genetic manipulation of live cells which is accelerating its adoption over traditional prokaryotic and eukaryotic expression methods. However, technical challenges related to optimizing cell lysate preparation and reaction conditions restrain the wider commercialization of this technique. Development of robust, standardized cell-free platforms optimized for different protein classes can help address existing shortcomings and expand applications. Growing deployment of continuous-exchange cell-free (CECF) methods and integrated systems coupling cell-free expression with downstream analysis presents lucrative opportunities in the market.

Key Features of the Study:

This report provides in-depth analysis of the global cell-free protein expression market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cell-free protein expression market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Takara Bio Inc., Merck KGaA, New England Biolabs, Bio-Rad Laboratories, Inc., Promega Corporation, Jena Bioscience GmbH, GeneCopoeia, Inc., CellFree Sciences Co., Ltd., Cube Biotech GmbH, Moderna Therapeutics, Biotechrabbit GmbH, and Profacgen

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global cell-free protein expression market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell-free protein expression market

Market Segmentation

  • By Product Type Insights (Revenue, USD Mn, 2019 - 2031)
    • Expression Systems
    • Insect Cells Cell-free Protein Expression System
    • coli Cell-free Protein Expression System
    • Rabbit Reticulocytes Cell-free Protein Expression System
    • Others
    • Reagents
    • Others (Vectors, yeast cell extracts, etc.)
  • By Application Insights (Revenue, USD Mn, 2019 - 2031)
    • Enzyme Engineering
    • High Throughput Production
    • Protein-Protein interaction
    • Others (High Throughput Production, etc.)
  • By End User Insights (Revenue, USD Mn, 2019 - 2031)
    • Biotechnological Companies
    • Pharmaceutical Companies
    • Contract Research Organizations
    • Others (Academic and Research Institutes, etc.)
  • Regional Insights (Revenue, USD Mn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific, Inc.
    • Takara Bio Inc.
    • Merck KGaA
    • New England Biolabs
    • Bio-Rad Laboratories, Inc.
    • Promega Corporation
    • Jena Bioscience GmbH
    • GeneCopoeia, Inc.
    • CellFree Sciences Co., Ltd.
    • Cube Biotech GmbH
    • Moderna Therapeutics
    • Biotechrabbit GmbH
    • Profacgen
Product Code: CMI1082

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Cell-free Protein Expression Market, By Product Type
    • Cell-free Protein Expression Market, By Application
    • Cell-free Protein Expression Market, By End User
    • Cell-free Protein Expression Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Market Trends
  • Key Developments

4. Global Cell-free Protein Expression Market, By Product Type, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Expression Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Insect Cells Cell-free Protein Expression System
  • coli Cell-free Protein Expression System
  • Rabbit Reticulocytes Cell-free Protein Expression System
  • Others
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others (Vectors, yeast cell extracts, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Cell-free Protein Expression Market, By Application, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Enzyme Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • High Throughput Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Protein-Protein interaction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others (High Throughput Production, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Cell-free Protein Expression Market, By End User, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Biotechnological Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others (Academic and Research Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Cell-free Protein Expression Market, By Region, 2019 - 2031, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jena Bioscience GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GeneCopoeia, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CellFree Sciences Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cube Biotech GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Moderna Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biotechrabbit GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Profacgen
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!